These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 33385163)

  • 1. CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer.
    Cairns J; Ly RC; Niu N; Kalari KR; Carlson EE; Wang L
    NAR Cancer; 2020 Dec; 2(4):zcaa039. PubMed ID: 33385163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the stability and activity of CDC25A and CDC25B by protein phosphatase PP2A and 14-3-3 binding.
    Kohama Y; Saito M; Yada M; Sakurai H
    Cell Signal; 2019 Feb; 54():10-16. PubMed ID: 30468767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase.
    Wu Y; Song P; Xu J; Zhang M; Zou MH
    J Biol Chem; 2007 Mar; 282(13):9777-9788. PubMed ID: 17255104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
    Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
    Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56α subunit.
    Kawashima I; Kirito K
    Exp Hematol; 2016 Dec; 44(12):1156-1165.e4. PubMed ID: 27576133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual specificity phosphatase Cdc25B, but not the closely related Cdc25C, is capable of inhibiting cellular proliferation in a manner dependent upon its catalytic activity.
    Varmeh-Ziaie S; Manfredi JJ
    J Biol Chem; 2007 Aug; 282(34):24633-41. PubMed ID: 17591782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase CK2 regulates CDC25B phosphatase activity.
    Theis-Febvre N; Filhol O; Froment C; Cazales M; Cochet C; Monsarrat B; Ducommun B; Baldin V
    Oncogene; 2003 Jan; 22(2):220-32. PubMed ID: 12527891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.
    Song GQ; Zhao Y
    Tumour Biol; 2015 Jul; 36(7):5001-9. PubMed ID: 25680404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of MAPK, PKA and PP2A in the regulation of MPF activity in Bufo arenarum oocytes.
    Toranzo GS; Bonilla F; Bühler MC; Bühler MI
    Zygote; 2011 May; 19(2):181-9. PubMed ID: 20880425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdc25B activity is regulated by 14-3-3.
    Forrest A; Gabrielli B
    Oncogene; 2001 Jul; 20(32):4393-401. PubMed ID: 11466620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase A regulates resumption of meiosis by phosphorylation of Cdc25B in mammalian oocytes.
    Pirino G; Wescott MP; Donovan PJ
    Cell Cycle; 2009 Feb; 8(4):665-70. PubMed ID: 19223768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-activated mitogen-activated protein kinases c-Jun NH2-terminal kinase and p38 target Cdc25B for degradation.
    Uchida S; Yoshioka K; Kizu R; Nakagama H; Matsunaga T; Ishizaka Y; Poon RY; Yamashita K
    Cancer Res; 2009 Aug; 69(16):6438-44. PubMed ID: 19638579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.
    Arachchige Don AS; Dallapiazza RF; Bennin DA; Brake T; Cowan CE; Horne MC
    Exp Cell Res; 2006 Dec; 312(20):4181-204. PubMed ID: 17123511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polo-like kinase 1 regulates CDC25B-dependent mitosis entry.
    Lobjois V; Jullien D; Bouché JP; Ducommun B
    Biochim Biophys Acta; 2009 Mar; 1793(3):462-8. PubMed ID: 19185590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases.
    Ferguson AM; White LS; Donovan PJ; Piwnica-Worms H
    Mol Cell Biol; 2005 Apr; 25(7):2853-60. PubMed ID: 15767688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
    Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
    Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells.
    Dai C; Zhang X; Xie D; Tang P; Li C; Zuo Y; Jiang B; Xue C
    Oncotarget; 2017 Nov; 8(56):95810-95823. PubMed ID: 29221169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc25B as a steroid receptor coactivator.
    Chua SS; Ma Z; Ngan E; Tsai SY
    Vitam Horm; 2004; 68():231-56. PubMed ID: 15193457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea.
    Nishijima H; Nishitani H; Seki T; Nishimoto T
    J Cell Biol; 1997 Sep; 138(5):1105-16. PubMed ID: 9281587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
    Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
    Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.